NHSBSA - Freedom of Information

You are at: NHSBSA Home Page | Freedom of Information

Previous Request List - Detail

Request Reference: 8899 Request Date: 16 Nov 2019
Request: Hi Please could you advise if Herceptin (Trastuzumab) has been prescribed off label as a monotherapy (no previous chemotherapy) for early stage HER2 positive breast cancer by the NHS. This would not follow NICE recommendations but is allowed by the FDA. If so please could you advise how many times this has been allowed per year and in what NHS Trusts. Many thanks for your help, Regards, [Name redacted]

Status: Complete
Response Date: 26 Nov 2019
Response: Please see attached response.